Measuring fasting serum insulin (FINS) levels and differentiating between the two types of hyperinsulinemia might provide us with useful information to tailor the treatment regimens of patients receiving either insulin or insulin analog treatment. The gene discussed is INS; the disease is hyperinsulinism.